לקסיבה

国: イスラエル

言語: ヘブライ語

ソース: Ministry of Health

有効成分:

FOSAMPRENAVIR AS FOSAMPRENAVIR CALCIUM 700 MG

から入手可能:

GLAXO SMITH KLINE (ISRAEL) LTD

ATCコード:

J05AE07

医薬品形態:

TABLETS

投与経路:

PER OS

製:

GLAXO WELLCOME SA, SPAIN

治療群:

FOSAMPRENAVIR

適応症:

Lexiva is indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV) infection in adults. The following points should be considered when initiating therapy with Lexiva/ritonavir in protease inhibitor - experienced patients: - The protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that Lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - Once - daily administration of Lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

承認日:

2012-01-01